Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study
Sentinel lymph node biopsy (SLNB) is an accurate, safe method for determining the axillary lymph node status. However, insufficient evidence exists to support the recommendation of SLNB in patients who have had neoadjuvant chemotherapy (NAC) to downsize tumours and allow for breast conservation surg...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103850/ https://www.ncbi.nlm.nih.gov/pubmed/27882235 http://dx.doi.org/10.3892/mco.2016.1025 |
_version_ | 1782466655336529920 |
---|---|
author | Parada, David Peña, Karla B. Riu, F. Francesc Aguilar, A. Esther Cohan, Sebastian |
author_facet | Parada, David Peña, Karla B. Riu, F. Francesc Aguilar, A. Esther Cohan, Sebastian |
author_sort | Parada, David |
collection | PubMed |
description | Sentinel lymph node biopsy (SLNB) is an accurate, safe method for determining the axillary lymph node status. However, insufficient evidence exists to support the recommendation of SLNB in patients who have had neoadjuvant chemotherapy (NAC) to downsize tumours and allow for breast conservation surgery. The present study aimed to use molecular approaches to evaluate the feasibility and accuracy of SLNB in patients treated with NAC prior to SLN mapping and surgery. A total of 50 consecutive patients with operable invasive breast carcinomas who had received prior NAC were assessed using the one-step nucleic acid amplification (OSNA) method. The rate of SLN identification was 100%. The OSNA assay showed that 29 patients (58%) were negative for SLN and 21 patients (42%) were positive. In 19 of these 21 patients (90.48%), the SLN was the only positive lymph node. No axillary lymph nodes metastases were observed in patients with isolated tumour cells or with micrometastases. The OSNA assay is a highly sensitive, specific and reproducible diagnostic technique that can be used to analyse SLNs following NAC. The total tumoral load may assist with predicting additional non-SLN metastases. |
format | Online Article Text |
id | pubmed-5103850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-51038502016-11-23 Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study Parada, David Peña, Karla B. Riu, F. Francesc Aguilar, A. Esther Cohan, Sebastian Mol Clin Oncol Articles Sentinel lymph node biopsy (SLNB) is an accurate, safe method for determining the axillary lymph node status. However, insufficient evidence exists to support the recommendation of SLNB in patients who have had neoadjuvant chemotherapy (NAC) to downsize tumours and allow for breast conservation surgery. The present study aimed to use molecular approaches to evaluate the feasibility and accuracy of SLNB in patients treated with NAC prior to SLN mapping and surgery. A total of 50 consecutive patients with operable invasive breast carcinomas who had received prior NAC were assessed using the one-step nucleic acid amplification (OSNA) method. The rate of SLN identification was 100%. The OSNA assay showed that 29 patients (58%) were negative for SLN and 21 patients (42%) were positive. In 19 of these 21 patients (90.48%), the SLN was the only positive lymph node. No axillary lymph nodes metastases were observed in patients with isolated tumour cells or with micrometastases. The OSNA assay is a highly sensitive, specific and reproducible diagnostic technique that can be used to analyse SLNs following NAC. The total tumoral load may assist with predicting additional non-SLN metastases. D.A. Spandidos 2016-11 2016-09-21 /pmc/articles/PMC5103850/ /pubmed/27882235 http://dx.doi.org/10.3892/mco.2016.1025 Text en Copyright: © Parada et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Parada, David Peña, Karla B. Riu, F. Francesc Aguilar, A. Esther Cohan, Sebastian Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study |
title | Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study |
title_full | Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study |
title_fullStr | Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study |
title_full_unstemmed | Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study |
title_short | Intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional study |
title_sort | intraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: an institutional study |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103850/ https://www.ncbi.nlm.nih.gov/pubmed/27882235 http://dx.doi.org/10.3892/mco.2016.1025 |
work_keys_str_mv | AT paradadavid intraoperativemolecularanalysisofsentinellymphnodesfollowingneoadjuvantchemotherapyinpatientswithclinicalnodenegativebreastcanceraninstitutionalstudy AT penakarlab intraoperativemolecularanalysisofsentinellymphnodesfollowingneoadjuvantchemotherapyinpatientswithclinicalnodenegativebreastcanceraninstitutionalstudy AT riuffrancesc intraoperativemolecularanalysisofsentinellymphnodesfollowingneoadjuvantchemotherapyinpatientswithclinicalnodenegativebreastcanceraninstitutionalstudy AT aguilaraesther intraoperativemolecularanalysisofsentinellymphnodesfollowingneoadjuvantchemotherapyinpatientswithclinicalnodenegativebreastcanceraninstitutionalstudy AT cohansebastian intraoperativemolecularanalysisofsentinellymphnodesfollowingneoadjuvantchemotherapyinpatientswithclinicalnodenegativebreastcanceraninstitutionalstudy |